Transcriptional regulation of latent feline immunodeficiency virus in peripheral CD4+ T-lymphocytes

Viruses

Volumn 4, Issue 5, 2012, Pages 878-888

  McDonnel, Samantha J ^a   Sparger, Ellen E ^b   Luciw, Paul A ^b   Murphy, Brian G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD4 T cells; Chromatin; FIV; Latency; Lentivirus; Transcription

Indexed keywords

RNA POLYMERASE II;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN STRUCTURE; DEMETHYLATION; FELINE IMMUNODEFICIENCY VIRUS; HISTONE ACETYLATION; LATENT VIRUS INFECTION; LYMPHOCYTE COUNT; NONHUMAN; PROMOTER REGION; TRANSCRIPTION REGULATION; VIRUS GENOME; VIRUS LATENCY; VIRUS LOAD; VIRUS STRAIN;

ANIMAL EXPERIMENTATION; ANIMALS; CATS; CD4-POSITIVE T-LYMPHOCYTES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE EXPRESSION REGULATION, VIRAL; IMMUNODEFICIENCY VIRUS, FELINE; PROVIRUSES; TRANSCRIPTION, GENETIC; VIRAL LOAD; VIRUS LATENCY; VIRUS REPLICATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 84861568322     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v4050878     Document Type: Article

References (26)

1. Kanzaki, L.I.; Looney, D.J. Feline immunodeficiency virus: A concise review. Front. Biosci. 2004, 9, 370-377.
2. Burkhard, M.J.; Dean, G.A. Transmission and immunopathogenesis of fiv in cats as a model for hiv. Curr. HIV Res. 2003, 1, 15-29.
3. Elder, J.H.; Lin, Y.C.; Fink, E.; Grant, C.K. Feline immunodeficiency virus (fiv) as a model for study of lentivirus infections: Parallels with hiv. Curr. HIV Res. 2010, 8, 73-80.
4. Diehl, L.J.; Mathiason-Dubard, C.K.; O'Neil, L.L.; Obert, L.A.; Hoover, E.A. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J. Virol. 1995, 69, 6149-6157.
5. Murphy, B.; Vapniarsky, N.; Hillman, C.; Castillo, D.; McDonnel, S.; Moore, P.; Luciw, P.A.; Sparger, E.E. Fiv establishes a latent infection in feline peripheral blood cd4+ t lymphocytes in vivo during the asymptomatic phase of infection. Retrovirology 2012, 9, doi:10.1186/1742-4690-9-12.
6. Chun, T.W.; Carruth, L.; Finzi, D.; Shen, X.; DiGiuseppe, J.A.; Taylor, H.; Hermankova, M.; Chadwick, K.; Margolick, J.; Quinn, T.C.; et al. Quantification of latent tissue reservoirs and total body viral load in hiv-1 infection. Nature 1997, 387, 183-188.
7. Josefsson, L.; King, M.S.; Makitalo, B.; Brannstrom, J.; Shao, W.; Maldarelli, F.; Kearney, M.F.; Hu, W.S.; Chen, J.; Gaines, H.; et al. Majority of cd4+ t cells from peripheral blood of hiv-1-infected individuals contain only one hiv DNA molecule. Proc. Natl. Acad. Sci. USA 2011, 108, 11199-11204.
8. Pedersen, N.C.; Leutenegger, C.M.; Woo, J.; Higgins, J. Virulence differences between two field isolates of feline immunodeficiency virus (fiv-apetaluma and fiv-cpgammar) in young adult specific pathogen free cats. Vet. Immunol. Immunopathol. 2001, 79, 53-67.
9. Pace, M.J.; Agosto, L.; Graf, E.H.; O'Doherty, U. Hiv reservoirs and latency models. Virology 2011, 411, 344-354.
10. Colin, L.; van Lint, C. Molecular control of hiv-1 postintegration latency: Implications for the development of new therapeutic strategies. Retrovirology 2009, 6, doi:10.1186/1742-4690-6-111.
11. Liu, G.; Xia, T.; Chen, X. The activation domains, the proline-rich domain, and the c-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/creb-binding protein. J. Biol. Chem. 2003, 278, 17557-17565.
12. Zhang, Z.; Klatt, A.; Gilmour, D.S.; Henderson, A.J. Negative elongation factor nelf represses human immunodeficiency virus transcription by pausing the rna polymerase II complex. J. Biol. Chem. 2007, 282, 16981-16988.
13. Lenasi, T.; Contreras, X.; Peterlin, B.M. Transcriptional interference antagonizes proviral gene expression to promote hiv latency. Cell Host Microbe 2008, 4, 123-133.
14. Peterlin, B.M.; Price, D.H. Controlling the elongation phase of transcription with p-tefb. Mol. Cell 2006, 23, 297-305.
15. Adams, M.; Sharmeen, L.; Kimpton, J.; Romeo, J.M.; Garcia, J.V.; Peterlin, B.M.; Groudine, M.; Emerman, M. Cellular latency in human immunodeficiency virus-infected individuals with high cd4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 1994, 91, 3862-3866.
16. Chatterji, U.; de Parseval, A.; Elder, J.H. Feline immunodeficiency virus orfa is distinct from other lentivirus transactivators. J. Virol. 2002, 76, 9624-9634.
17. Gemeniano, M.C.; Sawai, E.T.; Leutenegger, C.M.; Sparger, E.E. Feline immunodeficiency virus orf-ais required for virus particle formation and virus infectivity. J. Virol. 2003, 77, 8819-8830.
18. Trono, D.; Van Lint, C.; Rouzioux, C.; Verdin, E.; Barre-Sinoussi, F.; Chun, T.W.; Chomont, N. Hiv persistence and the prospect of long-term drug-free remissions for hiv-infected individuals. Science 2010, 329, 174-180.
19. Chomont, N.; El-Far, M.; Ancuta, P.; Trautmann, L.; Procopio, F.A.; Yassine-Diab, B.; Boucher, G.; Boulassel, M.R.; Ghattas, G.; Brenchley, J.M.; et al. Hiv reservoir size and persistence are driven by t cell survival and homeostatic proliferation. Nat. Med. 2009, 15, 893-900.
20. Blankson, J.N.; Persaud, D.; Siliciano, R.F. The challenge of viral reservoirs in hiv-1 infection. Annu. Rev. Med. 2002, 53, 557-593.
21. Chun, T.W.; Stuyver, L.; Mizell, S.B.; Ehler, L.A.; Mican, J.A.; Baseler, M.; Lloyd, A.L.; Nowak, M.A.; Fauci, A.S. Presence of an inducible hiv-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 1997, 94, 13193-13197.
22. Margolis, D.M. Mechanisms of hiv latency: An emerging picture of complexity. Curr. HIV/AIDS Rep. 2010, 7, 37-43.
23. Imai, K.; Togami, H.; Okamoto, T. Involvement of histone h3 lysine 9 (h3k9) methyltransferase g9a in the maintenance of hiv-1 latency and its reactivation by bix01294. J. Biol. Chem. 2010, 285, 16538-16545.
24. Margolis, D.M. Histone deacetylase inhibitors and hiv latency. Curr. Opin. HIV AIDS 2011, 6, 25-29.
25. Friedman, J.; Cho, W.K.; Chu, C.K.; Keedy, K.S.; Archin, N.M.; Margolis, D.M.; Karn, J. Epigenetic silencing of hiv-1 by the histone h3 lysine 27 methyltransferase enhancer of zeste 2. J. Virol. 2011, 85, 9078-9089.
26. Geeraert, L.; Kraus, G.; Pomerantz, R.J. Hide-and-seek: The challenge of viral persistence in hiv-1 infection. Annu. Rev. Med. 2008, 59, 487-501.